Works matching IS 02533766 AND DT 2022 AND VI 44 AND IP 12

Results: 17

相位角用于构建恶性肿瘤患者营养评估预测模型的探索.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1376, doi. 10.3760/cma.j.cn.112152-20210719-00521

By:

张晓玲;
赵文琪;
杜云毅;
张莹;
李玮玲;
胡文庆;
路静;
赵军

Publication type:

Article

人表皮生长因子受体 2 阳性曲妥珠单抗原发耐药晚期乳腺癌长期缓解 1 例.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1390, doi. 10.3760/cma.j.cn.112152-20220620-00437

By:

吴凡;
陈木兰;
黄伟炜;
刘健

Publication type:

Article

直肠癌根治术后患者行完全腹腔镜回肠造口还纳术的近期疗效.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1385, doi. 10.3760/cma.j.cn.112152-20200710-00643

By:

罗寿;
苏昊;
徐正;
周金涛;
马运宾;
陈怀罡;
刘明;
龚利彪;
杨甫;
吴学队;
袁铭;
张明光;
梁建伟;
刘骞;
周志祥;
王锡山;
周海涛

Publication type:

Article

初诊多发性骨髓瘤的代谢轮廓及其代谢通路.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1369, doi. 10.3760/cma.j.cn.112152-20201212-01066

By:

黄倩蕾;
赵冉冉;
杨冰玉;
蒋若雨;
杨露露;
颜霜;
傅铮铮;
吴德沛;
吴小津

Publication type:

Article

SUMO 特异性蛋白酶 1 诱导蛋白质去小泛素相关修饰增加子宫内膜癌侧群细胞化疗敏感性.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1362, doi. 10.3760/cma.j.cn.112152-20201108-00968

By:

袁梦岚;
白洁;
李承尧;
薛娜;
陈旭红;
盛凤;
刘晓智;
李圃

Publication type:

Article

1972-2016 年江苏省启东市结直肠癌生存率长期趋势分析.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1357, doi. 10.3760/cma.j.cn.112152-20220308-00159

By:

蒋明博;
陈永胜;
王军;
徐源佑;
丁璐璐;
张永辉;
陈建国;
朱健

Publication type:

Article

1972—2016 年江苏省启东市胃癌生存率长期趋势分析.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1352, doi. 10.3760/cma.j.cn.112152-20211028-00794

By:

薛晨;
丁璐璐;
王军;
陈永胜;
张永辉;
陈建国;
朱健;
肖静

Publication type:

Article

免疫检查点抑制剂相关垂体免疫不良反应的诊治.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1344, doi. 10.3760/cma.j.cn.112152-20211223-00967

By:

顾阳春;
谢超;
曹宝山

Publication type:

Article

中国肾癌规范诊疗质量控制指标 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1256, doi. 10.3760/cma.j.cn112152-20220803-00533

By:

何志嵩

Publication type:

Article

中国胃肠胰神经内分泌肿瘤专家共识 (2022 年版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1305, doi. 10.3760/cma.j.cn.112152-20220812-00550

By:

白春梅;
徐建明

Publication type:

Article

乳腺癌 CDK4/6 抑制剂相关性不良反应管理共识.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1296, doi. 10.3760/cma.j.cn.112152-20220825-00578

By:

葛睿;
王碧芸;
江泽飞

Publication type:

Article

人表皮生长因子受体 2 低表达乳腺癌临床诊疗共识 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1288, doi. 10.3760/cma.j.cn.112152-20220914-00623

By:

袁芃;
徐兵河

Publication type:

Article

中国晚期乳腺癌规范诊疗指南 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1262, doi. 10.3760/cma.j.cn112152-20221007-00680

By:

徐兵河;
马飞

Publication type:

Article

肿瘤大数据与真实世界研究中国专家共识 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1330, doi. 10.3760/cma.j.cn.112152-20220628-00458

By:

张艳桥;
徐建明

Publication type:

Article

中国胰腺癌规范诊疗质量控制指标 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1249, doi. 10.3760/cma.j.cn.112152-20220905-00600

By:

郝继辉

Publication type:

Article

中国食管癌规范诊疗质量控制指标 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1242, doi. 10.3760/cma.j.cn.112152-20220905-00599

By:

王绿化;
李印

Publication type:

Article

中国原发性喉癌规范诊疗质量控制指标 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1235, doi. 10.3760/cma.j.cn.112152-20220816-00558

By:

易俊林

Publication type:

Article